
Vir Biotechnology Appoints Mark Eisner As EVP And Chief Medical Officer
Immunology company Vir Biotechnology, Inc. (VIR) announced Wednesday that Mark Eisner will join the company as Executive Vice President and Chief Medical Officer (CMO), effective June 03, 2024. Eisner will be a part of the company\'s Executive Management Team and will report directly to Chief Executive Officer Marianne De Backer. Eisner brings to Vir deep...